Scientists use High-Tech scans to watch cancer drugs in action
NCT ID NCT05068102
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 26 times
Summary
This early-phase study involves 14 adults with advanced head and neck, lung, or skin cancer who have not responded to prior treatments. Researchers use PET/CT scans to track where two experimental drugs (BI 765063 and BI 770371) go in the body and how much they reach tumors. Participants also receive a standard immune-boosting drug called ezabenlimab. The goal is to understand drug behavior, not to cure or control the disease directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
VU University Medical Center
Amsterdam, 1081HV, Netherlands
Conditions
Explore the condition pages connected to this study.